Bayesian Capital Management, LP Organon & Co. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
A detailed history of Bayesian Capital Management, LP transactions in Organon & Co. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,200 shares of OGN stock, worth $174,272. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,200
Previous 42,000
73.33%
Holding current value
$174,272
Previous $869,000
75.37%
% of portfolio
0.03%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding OGN
# of Institutions
792Shares Held
203MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$507 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$470 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$174 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$152 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$140 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.96B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...